Belgian Economic Mission Norway

17–19 Jun 2024 | Norway

Stig TOLLEFSEN

Technology Office Lead

CEPI

Oslo, Norway

3 profile visitsSpeaker

Representing CEPI, looking for innovative vaccine technology platforms that can support the 100-Day mission.

My organisation

CEPI

CEPI

Other

Oslo, Norway

CEPI is a global partnership working to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats with focus on viral infectious diseases where there is no commercial insentive to develop vaccines.
Read more

About me

I joined CEPI in 2018 and am currently serving the role as Technology Office lead in Research & Development Innovations (RDI) Depratment in CEPI. RDI is an External R&D office, looking for new innovative technologies that could support the 100 day mission. In CEPI I have been the gate keeper for the 5 rounds of COVID-19 vaccine development calls for proposals and in addition established the TechTalks which is a meeting platform to discuss innovative developments by meeting developers from across the globe and getting a good overview of promising innovations being developed. Towards the end of 2023 I have been the project lead for the new call for proposals "Innovations to Prepare for Future Epidemics and Pandemics" looking for innovative new vaccine technology platforms.

I have a background as a biochemist and immunologist from Oslo University/ University Hospital working first with DNA vaccines and later with autoimmune diseases. I have also been the head of section for immunology and the Norwegian Veterinary Institute.

My organisation

CEPI is a global partnership working to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats with focus on viral infectious diseases where there is no commercial insentive to develop vaccines.

Social media

Skills

  • Vaccine technologies
  • Immunology

Interests

  • Vaccine technologies
  • Vaccine innovations
  • Vaccine technology platforms

Speaker sessions (1)

Monday, 17 June 2024